+1 347 708 0418
The Point of Care Diagnostics (POCD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Point of Care Diagnostics (POCD) size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Point of Care Diagnostics (POCD) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Point of Care Diagnostics (POCD) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Others
Market segment by Application, can be divided into
Clinics
Hospitals
Assisted Living Healthcare Facilities
Laboratory
Market segment by players, this report covers
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
QIAGEN
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Instrumentation Laboratory
Sekisui Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Point of Care Diagnostics (POCD) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Point of Care Diagnostics (POCD), with revenue, gross margin and global market share of Point of Care Diagnostics (POCD) from 2019 to 2021.
Chapter 3, the Point of Care Diagnostics (POCD) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Point of Care Diagnostics (POCD) market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Point of Care Diagnostics (POCD) research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Point of Care Diagnostics (POCD)
1.2 Classification of Point of Care Diagnostics (POCD) by Type
1.2.1 Overview: Global Point of Care Diagnostics (POCD) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Point of Care Diagnostics (POCD) Revenue Market Share by Type in 2020
1.2.3 Blood Glucose Testing
1.2.4 Infectious Diseases Testing
1.2.5 Cardiac Markers Testing
1.2.6 Coagulation Testing
1.2.7 Pregnancy and Fertility Testing
1.2.8 Blood Gas/Electrolytes Testing
1.2.9 Tumor Markers Testing
1.2.10 Urinalysis Testing
1.2.11 Cholesterol Testing
1.2.12 Others
1.3 Global Point of Care Diagnostics (POCD) Market by Application
1.3.1 Overview: Global Point of Care Diagnostics (POCD) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Assisted Living Healthcare Facilities
1.3.5 Laboratory
1.4 Global Point of Care Diagnostics (POCD) Market Size & Forecast
1.5 Global Point of Care Diagnostics (POCD) Market Size and Forecast by Region
1.5.1 Global Point of Care Diagnostics (POCD) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Point of Care Diagnostics (POCD) Market Size by Region, (2016-2021)
1.5.3 North America Point of Care Diagnostics (POCD) Market Size and Prospect (2016-2026)
1.5.4 Europe Point of Care Diagnostics (POCD) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Point of Care Diagnostics (POCD) Market Size and Prospect (2016-2026)
1.5.6 South America Point of Care Diagnostics (POCD) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Point of Care Diagnostics (POCD) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Point of Care Diagnostics (POCD) Market Drivers
1.6.2 Point of Care Diagnostics (POCD) Market Restraints
1.6.3 Point of Care Diagnostics (POCD) Trends Analysis
2 Company Profiles
2.1 Alere
2.1.1 Alere Details
2.1.2 Alere Major Business
2.1.3 Alere Point of Care Diagnostics (POCD) Product and Solutions
2.1.4 Alere Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Alere Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Point of Care Diagnostics (POCD) Product and Solutions
2.2.4 Roche Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Roche Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Point of Care Diagnostics (POCD) Product and Solutions
2.3.4 Abbott Laboratories Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Point of Care Diagnostics (POCD) Product and Solutions
2.4.4 Johnson & Johnson Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Siemens Healthcare
2.5.1 Siemens Healthcare Details
2.5.2 Siemens Healthcare Major Business
2.5.3 Siemens Healthcare Point of Care Diagnostics (POCD) Product and Solutions
2.5.4 Siemens Healthcare Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Siemens Healthcare Recent Developments and Future Plans
2.6 Danaher
2.6.1 Danaher Details
2.6.2 Danaher Major Business
2.6.3 Danaher Point of Care Diagnostics (POCD) Product and Solutions
2.6.4 Danaher Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Danaher Recent Developments and Future Plans
2.7 QIAGEN
2.7.1 QIAGEN Details
2.7.2 QIAGEN Major Business
2.7.3 QIAGEN Point of Care Diagnostics (POCD) Product and Solutions
2.7.4 QIAGEN Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 QIAGEN Recent Developments and Future Plans
2.8 Bayer Healthcare
2.8.1 Bayer Healthcare Details
2.8.2 Bayer Healthcare Major Business
2.8.3 Bayer Healthcare Point of Care Diagnostics (POCD) Product and Solutions
2.8.4 Bayer Healthcare Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Bayer Healthcare Recent Developments and Future Plans
2.9 Beckman Coulter
2.9.1 Beckman Coulter Details
2.9.2 Beckman Coulter Major Business
2.9.3 Beckman Coulter Point of Care Diagnostics (POCD) Product and Solutions
2.9.4 Beckman Coulter Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Beckman Coulter Recent Developments and Future Plans
2.10 Nipro Diagnostics
2.10.1 Nipro Diagnostics Details
2.10.2 Nipro Diagnostics Major Business
2.10.3 Nipro Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
2.10.4 Nipro Diagnostics Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Nipro Diagnostics Recent Developments and Future Plans
2.11 Bio-Rad Laboratories
2.11.1 Bio-Rad Laboratories Details
2.11.2 Bio-Rad Laboratories Major Business
2.11.3 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Product and Solutions
2.11.4 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.12 Nova Biomedical
2.12.1 Nova Biomedical Details
2.12.2 Nova Biomedical Major Business
2.12.3 Nova Biomedical Point of Care Diagnostics (POCD) Product and Solutions
2.12.4 Nova Biomedical Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Nova Biomedical Recent Developments and Future Plans
2.13 BioMerieux
2.13.1 BioMerieux Details
2.13.2 BioMerieux Major Business
2.13.3 BioMerieux Point of Care Diagnostics (POCD) Product and Solutions
2.13.4 BioMerieux Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 BioMerieux Recent Developments and Future Plans
2.14 Quidel
2.14.1 Quidel Details
2.14.2 Quidel Major Business
2.14.3 Quidel Point of Care Diagnostics (POCD) Product and Solutions
2.14.4 Quidel Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Quidel Recent Developments and Future Plans
2.15 Helena Laboratories
2.15.1 Helena Laboratories Details
2.15.2 Helena Laboratories Major Business
2.15.3 Helena Laboratories Point of Care Diagnostics (POCD) Product and Solutions
2.15.4 Helena Laboratories Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Helena Laboratories Recent Developments and Future Plans
2.16 OraSure Technologies
2.16.1 OraSure Technologies Details
2.16.2 OraSure Technologies Major Business
2.16.3 OraSure Technologies Point of Care Diagnostics (POCD) Product and Solutions
2.16.4 OraSure Technologies Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 OraSure Technologies Recent Developments and Future Plans
2.17 Accriva
2.17.1 Accriva Details
2.17.2 Accriva Major Business
2.17.3 Accriva Point of Care Diagnostics (POCD) Product and Solutions
2.17.4 Accriva Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Accriva Recent Developments and Future Plans
2.18 Abaxis
2.18.1 Abaxis Details
2.18.2 Abaxis Major Business
2.18.3 Abaxis Point of Care Diagnostics (POCD) Product and Solutions
2.18.4 Abaxis Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Abaxis Recent Developments and Future Plans
2.19 Chembio Diagnostics
2.19.1 Chembio Diagnostics Details
2.19.2 Chembio Diagnostics Major Business
2.19.3 Chembio Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
2.19.4 Chembio Diagnostics Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Chembio Diagnostics Recent Developments and Future Plans
2.20 Trinity Biotech
2.20.1 Trinity Biotech Details
2.20.2 Trinity Biotech Major Business
2.20.3 Trinity Biotech Point of Care Diagnostics (POCD) Product and Solutions
2.20.4 Trinity Biotech Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Trinity Biotech Recent Developments and Future Plans
2.21 Instrumentation Laboratory
2.21.1 Instrumentation Laboratory Details
2.21.2 Instrumentation Laboratory Major Business
2.21.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Product and Solutions
2.21.4 Instrumentation Laboratory Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Instrumentation Laboratory Recent Developments and Future Plans
2.22 Sekisui Diagnostics
2.22.1 Sekisui Diagnostics Details
2.22.2 Sekisui Diagnostics Major Business
2.22.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
2.22.4 Sekisui Diagnostics Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2021)
2.22.5 Sekisui Diagnostics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Point of Care Diagnostics (POCD) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Point of Care Diagnostics (POCD) Players Market Share
3.2.2 Top 10 Point of Care Diagnostics (POCD) Players Market Share
3.2.3 Market Competition Trend
3.3 Point of Care Diagnostics (POCD) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Point of Care Diagnostics (POCD) Revenue and Market Share by Type (2016-2021)
4.2 Global Point of Care Diagnostics (POCD) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Point of Care Diagnostics (POCD) Revenue Market Share by Application (2016-2021)
5.2 Point of Care Diagnostics (POCD) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Point of Care Diagnostics (POCD) Revenue by Type (2016-2026)
6.2 North America Point of Care Diagnostics (POCD) Revenue by Application (2016-2026)
6.3 North America Point of Care Diagnostics (POCD) Market Size by Country
6.3.1 North America Point of Care Diagnostics (POCD) Revenue by Country (2016-2026)
6.3.2 United States Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
6.3.3 Canada Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
6.3.4 Mexico Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Point of Care Diagnostics (POCD) Revenue by Type (2016-2026)
7.2 Europe Point of Care Diagnostics (POCD) Revenue by Application (2016-2026)
7.3 Europe Point of Care Diagnostics (POCD) Market Size by Country
7.3.1 Europe Point of Care Diagnostics (POCD) Revenue by Country (2016-2026)
7.3.2 Germany Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
7.3.3 France Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
7.3.5 Russia Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
7.3.6 Italy Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Point of Care Diagnostics (POCD) Revenue by Type (2016-2026)
8.2 Asia-Pacific Point of Care Diagnostics (POCD) Revenue by Application (2016-2026)
8.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region
8.3.1 Asia-Pacific Point of Care Diagnostics (POCD) Revenue by Region (2016-2026)
8.3.2 China Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
8.3.3 Japan Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
8.3.4 South Korea Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
8.3.5 India Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
8.3.7 Australia Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Point of Care Diagnostics (POCD) Revenue by Type (2016-2026)
9.2 South America Point of Care Diagnostics (POCD) Revenue by Application (2016-2026)
9.3 South America Point of Care Diagnostics (POCD) Market Size by Country
9.3.1 South America Point of Care Diagnostics (POCD) Revenue by Country (2016-2026)
9.3.2 Brazil Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
9.3.3 Argentina Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Point of Care Diagnostics (POCD) Revenue by Type (2016-2026)
10.2 Middle East & Africa Point of Care Diagnostics (POCD) Revenue by Application (2016-2026)
10.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country
10.3.1 Middle East & Africa Point of Care Diagnostics (POCD) Revenue by Country (2016-2026)
10.3.2 Turkey Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
10.3.4 UAE Point of Care Diagnostics (POCD) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Point of Care Diagnostics (POCD) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Point of Care Diagnostics (POCD) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Point of Care Diagnostics (POCD) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Point of Care Diagnostics (POCD) Revenue (USD Million) by Region (2016-2021)
Table 5. Global Point of Care Diagnostics (POCD) Revenue Market Share by Region (2021-2026)
Table 6. Alere Corporate Information, Head Office, and Major Competitors
Table 7. Alere Major Business
Table 8. Alere Point of Care Diagnostics (POCD) Product and Solutions
Table 9. Alere Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Roche Corporate Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Point of Care Diagnostics (POCD) Product and Solutions
Table 13. Roche Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Laboratories Major Business
Table 16. Abbott Laboratories Point of Care Diagnostics (POCD) Product and Solutions
Table 17. Abbott Laboratories Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 19. Johnson & Johnson Major Business
Table 20. Johnson & Johnson Point of Care Diagnostics (POCD) Product and Solutions
Table 21. Johnson & Johnson Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
Table 23. Siemens Healthcare Major Business
Table 24. Siemens Healthcare Point of Care Diagnostics (POCD) Product and Solutions
Table 25. Siemens Healthcare Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Danaher Corporate Information, Head Office, and Major Competitors
Table 27. Danaher Major Business
Table 28. Danaher Point of Care Diagnostics (POCD) Product and Solutions
Table 29. Danaher Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 31. QIAGEN Major Business
Table 32. QIAGEN Point of Care Diagnostics (POCD) Product and Solutions
Table 33. QIAGEN Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Bayer Healthcare Corporate Information, Head Office, and Major Competitors
Table 35. Bayer Healthcare Major Business
Table 36. Bayer Healthcare Point of Care Diagnostics (POCD) Product and Solutions
Table 37. Bayer Healthcare Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 39. Beckman Coulter Major Business
Table 40. Beckman Coulter Point of Care Diagnostics (POCD) Product and Solutions
Table 41. Beckman Coulter Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Nipro Diagnostics Corporate Information, Head Office, and Major Competitors
Table 43. Nipro Diagnostics Major Business
Table 44. Nipro Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
Table 45. Nipro Diagnostics Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 47. Bio-Rad Laboratories Major Business
Table 48. Bio-Rad Laboratories Point of Care Diagnostics (POCD) Product and Solutions
Table 49. Bio-Rad Laboratories Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Nova Biomedical Corporate Information, Head Office, and Major Competitors
Table 51. Nova Biomedical Major Business
Table 52. Nova Biomedical Point of Care Diagnostics (POCD) Product and Solutions
Table 53. Nova Biomedical Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. BioMerieux Corporate Information, Head Office, and Major Competitors
Table 55. BioMerieux Major Business
Table 56. BioMerieux Point of Care Diagnostics (POCD) Product and Solutions
Table 57. BioMerieux Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Quidel Corporate Information, Head Office, and Major Competitors
Table 59. Quidel Major Business
Table 60. Quidel Point of Care Diagnostics (POCD) Product and Solutions
Table 61. Quidel Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Helena Laboratories Corporate Information, Head Office, and Major Competitors
Table 63. Helena Laboratories Major Business
Table 64. Helena Laboratories Point of Care Diagnostics (POCD) Product and Solutions
Table 65. Helena Laboratories Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. OraSure Technologies Corporate Information, Head Office, and Major Competitors
Table 67. OraSure Technologies Major Business
Table 68. OraSure Technologies Point of Care Diagnostics (POCD) Product and Solutions
Table 69. OraSure Technologies Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Accriva Corporate Information, Head Office, and Major Competitors
Table 71. Accriva Major Business
Table 72. Accriva Point of Care Diagnostics (POCD) Product and Solutions
Table 73. Accriva Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Abaxis Corporate Information, Head Office, and Major Competitors
Table 75. Abaxis Major Business
Table 76. Abaxis Point of Care Diagnostics (POCD) Product and Solutions
Table 77. Abaxis Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Chembio Diagnostics Corporate Information, Head Office, and Major Competitors
Table 79. Chembio Diagnostics Major Business
Table 80. Chembio Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
Table 81. Chembio Diagnostics Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Trinity Biotech Corporate Information, Head Office, and Major Competitors
Table 83. Trinity Biotech Major Business
Table 84. Trinity Biotech Point of Care Diagnostics (POCD) Product and Solutions
Table 85. Trinity Biotech Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Instrumentation Laboratory Corporate Information, Head Office, and Major Competitors
Table 87. Instrumentation Laboratory Major Business
Table 88. Instrumentation Laboratory Point of Care Diagnostics (POCD) Product and Solutions
Table 89. Instrumentation Laboratory Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Sekisui Diagnostics Corporate Information, Head Office, and Major Competitors
Table 91. Sekisui Diagnostics Major Business
Table 92. Sekisui Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
Table 93. Sekisui Diagnostics Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 94. Global Point of Care Diagnostics (POCD) Revenue (USD Million) by Players (2019-2021)
Table 95. Global Point of Care Diagnostics (POCD) Revenue Share by Players (2019-2021)
Table 96. Breakdown of Point of Care Diagnostics (POCD) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 97. Point of Care Diagnostics (POCD) Players Head Office, Products and Services Provided
Table 98. Point of Care Diagnostics (POCD) Mergers & Acquisitions in the Past Five Years
Table 99. Point of Care Diagnostics (POCD) New Entrants and Expansion Plans
Table 100. Global Point of Care Diagnostics (POCD) Revenue (USD Million) by Type (2016-2021)
Table 101. Global Point of Care Diagnostics (POCD) Revenue Share by Type (2016-2021)
Table 102. Global Point of Care Diagnostics (POCD) Revenue Forecast by Type (2021-2026)
Table 103. Global Point of Care Diagnostics (POCD) Revenue by Application (2016-2021)
Table 104. Global Point of Care Diagnostics (POCD) Revenue Forecast by Application (2021-2026)
Table 105. North America Point of Care Diagnostics (POCD) Revenue by Type (2016-2021) & (USD Million)
Table 106. North America Point of Care Diagnostics (POCD) Revenue by Type (2021-2026) & (USD Million)
Table 107. North America Point of Care Diagnostics (POCD) Revenue by Application (2016-2021) & (USD Million)
Table 108. North America Point of Care Diagnostics (POCD) Revenue by Application (2021-2026) & (USD Million)
Table 109. North America Point of Care Diagnostics (POCD) Revenue by Country (2016-2021) & (USD Million)
Table 110. North America Point of Care Diagnostics (POCD) Revenue by Country (2021-2026) & (USD Million)
Table 111. Europe Point of Care Diagnostics (POCD) Revenue by Type (2016-2021) & (USD Million)
Table 112. Europe Point of Care Diagnostics (POCD) Revenue by Type (2021-2026) & (USD Million)
Table 113. Europe Point of Care Diagnostics (POCD) Revenue by Application (2016-2021) & (USD Million)
Table 114. Europe Point of Care Diagnostics (POCD) Revenue by Application (2021-2026) & (USD Million)
Table 115. Europe Point of Care Diagnostics (POCD) Revenue by Country (2016-2021) & (USD Million)
Table 116. Europe Point of Care Diagnostics (POCD) Revenue by Country (2021-2026) & (USD Million)
Table 117. Asia-Pacific Point of Care Diagnostics (POCD) Revenue by Type (2016-2021) & (USD Million)
Table 118. Asia-Pacific Point of Care Diagnostics (POCD) Revenue by Type (2021-2026) & (USD Million)
Table 119. Asia-Pacific Point of Care Diagnostics (POCD) Revenue by Application (2016-2021) & (USD Million)
Table 120. Asia-Pacific Point of Care Diagnostics (POCD) Revenue by Application (2021-2026) & (USD Million)
Table 121. Asia-Pacific Point of Care Diagnostics (POCD) Revenue by Region (2016-2021) & (USD Million)
Table 122. Asia-Pacific Point of Care Diagnostics (POCD) Revenue by Region (2021-2026) & (USD Million)
Table 123. South America Point of Care Diagnostics (POCD) Revenue by Type (2016-2021) & (USD Million)
Table 124. South America Point of Care Diagnostics (POCD) Revenue by Type (2021-2026) & (USD Million)
Table 125. South America Point of Care Diagnostics (POCD) Revenue by Application (2016-2021) & (USD Million)
Table 126. South America Point of Care Diagnostics (POCD) Revenue by Application (2021-2026) & (USD Million)
Table 127. South America Point of Care Diagnostics (POCD) Revenue by Country (2016-2021) & (USD Million)
Table 128. South America Point of Care Diagnostics (POCD) Revenue by Country (2021-2026) & (USD Million)
Table 129. Middle East & Africa Point of Care Diagnostics (POCD) Revenue by Type (2016-2021) & (USD Million)
Table 130. Middle East & Africa Point of Care Diagnostics (POCD) Revenue by Type (2021-2026) & (USD Million)
Table 131. Middle East & Africa Point of Care Diagnostics (POCD) Revenue by Application (2016-2021) & (USD Million)
Table 132. Middle East & Africa Point of Care Diagnostics (POCD) Revenue by Application (2021-2026) & (USD Million)
Table 133. Middle East & Africa Point of Care Diagnostics (POCD) Revenue by Country (2016-2021) & (USD Million)
Table 134. Middle East & Africa Point of Care Diagnostics (POCD) Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Point of Care Diagnostics (POCD) Picture
Figure 2. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type in 2020
Figure 3. Blood Glucose Testing
Figure 4. Infectious Diseases Testing
Figure 5. Cardiac Markers Testing
Figure 6. Coagulation Testing
Figure 7. Pregnancy and Fertility Testing
Figure 8. Blood Gas/Electrolytes Testing
Figure 9. Tumor Markers Testing
Figure 10. Urinalysis Testing
Figure 11. Cholesterol Testing
Figure 12. Others
Figure 13. Point of Care Diagnostics (POCD) Revenue Market Share by Application in 2020
Figure 14. Clinics Picture
Figure 15. Hospitals Picture
Figure 16. Assisted Living Healthcare Facilities Picture
Figure 17. Laboratory Picture
Figure 18. Global Point of Care Diagnostics (POCD) Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 19. Global Point of Care Diagnostics (POCD) Revenue and Forecast (2016-2026) & (USD Million)
Figure 20. Global Point of Care Diagnostics (POCD) Revenue Market Share by Region (2016-2026)
Figure 21. Global Point of Care Diagnostics (POCD) Revenue Market Share by Region in 2020
Figure 22. North America Point of Care Diagnostics (POCD) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Europe Point of Care Diagnostics (POCD) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Asia-Pacific Point of Care Diagnostics (POCD) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. South America Point of Care Diagnostics (POCD) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 26. Middle East and Africa Point of Care Diagnostics (POCD) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 27. Point of Care Diagnostics (POCD) Market Drivers
Figure 28. Point of Care Diagnostics (POCD) Market Restraints
Figure 29. Point of Care Diagnostics (POCD) Market Trends
Figure 30. Alere Recent Developments and Future Plans
Figure 31. Roche Recent Developments and Future Plans
Figure 32. Abbott Laboratories Recent Developments and Future Plans
Figure 33. Johnson & Johnson Recent Developments and Future Plans
Figure 34. Siemens Healthcare Recent Developments and Future Plans
Figure 35. Danaher Recent Developments and Future Plans
Figure 36. QIAGEN Recent Developments and Future Plans
Figure 37. Bayer Healthcare Recent Developments and Future Plans
Figure 38. Beckman Coulter Recent Developments and Future Plans
Figure 39. Nipro Diagnostics Recent Developments and Future Plans
Figure 40. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 41. Nova Biomedical Recent Developments and Future Plans
Figure 42. BioMerieux Recent Developments and Future Plans
Figure 43. Quidel Recent Developments and Future Plans
Figure 44. Helena Laboratories Recent Developments and Future Plans
Figure 45. OraSure Technologies Recent Developments and Future Plans
Figure 46. Accriva Recent Developments and Future Plans
Figure 47. Abaxis Recent Developments and Future Plans
Figure 48. Chembio Diagnostics Recent Developments and Future Plans
Figure 49. Trinity Biotech Recent Developments and Future Plans
Figure 50. Instrumentation Laboratory Recent Developments and Future Plans
Figure 51. Sekisui Diagnostics Recent Developments and Future Plans
Figure 52. Global Point of Care Diagnostics (POCD) Revenue Share by Players in 2020
Figure 53. Point of Care Diagnostics (POCD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 54. Global Top 3 Players Point of Care Diagnostics (POCD) Revenue Market Share in 2020
Figure 55. Global Top 10 Players Point of Care Diagnostics (POCD) Revenue Market Share in 2020
Figure 56. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 57. Global Point of Care Diagnostics (POCD) Revenue Share by Type in 2020
Figure 58. Global Point of Care Diagnostics (POCD) Market Share Forecast by Type (2021-2026)
Figure 59. Global Point of Care Diagnostics (POCD) Revenue Share by Application in 2020
Figure 60. Global Point of Care Diagnostics (POCD) Market Share Forecast by Application (2021-2026)
Figure 61. North America Point of Care Diagnostics (POCD) Sales Market Share by Type (2016-2026)
Figure 62. North America Point of Care Diagnostics (POCD) Sales Market Share by Application (2016-2026)
Figure 63. North America Point of Care Diagnostics (POCD) Revenue Market Share by Country (2016-2026)
Figure 64. United States Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Canada Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Mexico Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Europe Point of Care Diagnostics (POCD) Sales Market Share by Type (2016-2026)
Figure 68. Europe Point of Care Diagnostics (POCD) Sales Market Share by Application (2016-2026)
Figure 69. Europe Point of Care Diagnostics (POCD) Revenue Market Share by Country (2016-2026)
Figure 70. Germany Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. France Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. United Kingdom Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Russia Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Italy Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Asia-Pacific Point of Care Diagnostics (POCD) Sales Market Share by Type (2016-2026)
Figure 76. Asia-Pacific Point of Care Diagnostics (POCD) Sales Market Share by Application (2016-2026)
Figure 77. Asia-Pacific Point of Care Diagnostics (POCD) Revenue Market Share by Region (2016-2026)
Figure 78. China Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Japan Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Korea Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. India Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Southeast Asia Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Australia Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. South America Point of Care Diagnostics (POCD) Sales Market Share by Type (2016-2026)
Figure 85. South America Point of Care Diagnostics (POCD) Sales Market Share by Application (2016-2026)
Figure 86. South America Point of Care Diagnostics (POCD) Revenue Market Share by Country (2016-2026)
Figure 87. Brazil Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 88. Argentina Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 89. Middle East and Africa Point of Care Diagnostics (POCD) Sales Market Share by Type (2016-2026)
Figure 90. Middle East and Africa Point of Care Diagnostics (POCD) Sales Market Share by Application (2016-2026)
Figure 91. Middle East and Africa Point of Care Diagnostics (POCD) Revenue Market Share by Country (2016-2026)
Figure 92. Turkey Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 93. Saudi Arabia Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 94. UAE Point of Care Diagnostics (POCD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 95. Methodology
Figure 96. Research Process and Data Source
Buy
